166 related articles for article (PubMed ID: 31066177)
1. Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.
Smith SM; Gurka MJ; Winterstein AG; Pepine CJ; Cooper-DeHoff RM
J Clin Hypertens (Greenwich); 2019 Jun; 21(6):825-834. PubMed ID: 31066177
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
3. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.
Beddhu S; Greene T; Boucher R; Cushman WC; Wei G; Stoddard G; Ix JH; Chonchol M; Kramer H; Cheung AK; Kimmel PL; Whelton PK; Chertow GM
Lancet Diabetes Endocrinol; 2018 Jul; 6(7):555-563. PubMed ID: 29685860
[TBL] [Abstract][Full Text] [Related]
4. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
5. Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.
Hwang AY; Dave CV; Smith SM
Am J Hypertens; 2018 Nov; 31(12):1324-1331. PubMed ID: 30052747
[TBL] [Abstract][Full Text] [Related]
6. Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy: A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials.
Collard D; Brouwer TF; Olde Engberink RHG; Zwinderman AH; Vogt L; van den Born BH
Hypertension; 2020 May; 75(5):1205-1212. PubMed ID: 32223381
[TBL] [Abstract][Full Text] [Related]
7. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
8. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
Chang TI; Lim H; Park CH; Rhee CM; Moradi H; Kalantar-Zadeh K; Kang EW; Kang SW; Han SH
Am J Kidney Dis; 2020 Aug; 76(2):224-232. PubMed ID: 32305207
[TBL] [Abstract][Full Text] [Related]
9. More Versus Less Blood Pressure Lowering: An Update.
Atkins ER; Rodgers A
Clin Ther; 2016 Oct; 38(10):2135-2141. PubMed ID: 27633256
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
[TBL] [Abstract][Full Text] [Related]
11. Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.
Smith SM; Gurka MJ; Calhoun DA; Gong Y; Pepine CJ; Cooper-DeHoff RM
Am J Med; 2018 Dec; 131(12):1463-1472.e7. PubMed ID: 30142317
[TBL] [Abstract][Full Text] [Related]
12. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.
Chen LY; Bigger JT; Hickey KT; Chen H; Lopez-Jimenez C; Banerji MA; Evans G; Fleg JL; Papademetriou V; Thomas A; Woo V; Seaquist ER; Soliman EZ
Am J Hypertens; 2016 Nov; 29(11):1276-1282. PubMed ID: 26476086
[TBL] [Abstract][Full Text] [Related]
13. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of a Simple Algorithm to Identify Hypertensive Patients Who Benefit from Intensive Blood Pressure Lowering.
Wang S; Khera R; Das SR; Vigen R; Wang T; Luo X; Lu R; Zhan X; Xiao G; Vongpatanasin W; Xie Y
Am J Cardiol; 2018 Jul; 122(2):248-254. PubMed ID: 29880288
[TBL] [Abstract][Full Text] [Related]
15. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
[TBL] [Abstract][Full Text] [Related]
16. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
[TBL] [Abstract][Full Text] [Related]
17. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
[TBL] [Abstract][Full Text] [Related]
18. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
[TBL] [Abstract][Full Text] [Related]
19. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.
Haddadin F; Sud K; Munoz Estrella A; Moctezuma S; Wu L; Berookhim J; Lucas CH; Patel D; Argulian E
J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1507-1515. PubMed ID: 31448866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
